Ultra-sensitive detection of circulating tumor DNA through genome-wide integration

A genome-wide, read-out technology, applied in the field of medical diagnosis, which can solve problems such as poor imaging technology

Pending Publication Date: 2021-04-02
CORNELL UNIVERSITY +1
View PDF7 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These data suggest that even ultra-deep sequencing is currently inferior to imaging technologies in terms of inclusiveness and / or precision in early disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ultra-sensitive detection of circulating tumor DNA through genome-wide integration
  • Ultra-sensitive detection of circulating tumor DNA through genome-wide integration
  • Ultra-sensitive detection of circulating tumor DNA through genome-wide integration

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0373] Example 1: Design of a Somatic Mutation Classifier

[0374]When designing models for classification of somatic mutations, it is important to identify sources of error that can lead to false positive somatic mutations. True mutations are likely to be of high base quality regardless of position in the read. Likewise, the read base, reference base, and alignment string (CIGAR) at the position of the true mutation may not be relevant to the read alignment. More specifically, true somatic mutations can be expected to be spatially invariant. It is well known that systematic errors in sequencing experiments depend on position in the reads, so while a mutation itself may be spatially invariant, its position in the reads is often not. Errors caused by mismapping are likely to contain repetitive sequences or very specific sequence motifs (eg TTAGGG in telomeres). Therefore, models that accurately represent the spatial invariance in real somatic mutations and errors due to mapp...

Embodiment approach

[0424] Based on the foregoing, the system and method can be developed as a complete early detection engine. Although the engine captures position in a read by using a fully connected sigmoid layer, some architectures may be better suited for capturing relative position in a read. Furthermore, additional sources of information contained in read pairs from DNA fragments, which were not included in the primary detection, can be used to determine the strand of origin (Watson or Crick) and estimate the size of the DNA fragment. It has been observed that ctDNA has a different fragment size distribution compared to regular circulating healthy DNA (Underhill et al., PLoS Genetics, 12(7):e1006162, 2016).

[0425] The aforementioned systems and methods can be integrated with a recurrent neural network (RNN). RNNs have now been shown to be a powerful tool for using length as a feature in bioinformatics at distances even up to 1kb, well beyond the size of ctDNA fragments (Hill et al., bi...

Embodiment approach 2

[0426] Embodiment 2: Methods and systems for detecting and validating tumor-specific low-abundance tumor markers and their use in cancer diagnosis

[0427] The disclosed systems and methods can be used for early diagnosis of cancer. As is known in the art, the abundance of ctDNA limits targeted sequencing techniques in the case of early stage cancer or residual disease detection compared to metastatic cancer (characterized by high disease burden and significantly elevated ctDNA) usage of. Considering the known limited amount of cfDNA in the setting of low tumor burden, first, the potential to optimize cfDNA extraction was investigated. First, to reduce variance derived from sample collection and inter-individual variation, uniform cfDNA material generated from large-volume plasma collection (approximately 300 cc) by plasmapheresis from healthy subjects and cancer patients undergoing hematopoietic stem cell collection was used, Commercially available extraction kits and metho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The disclosure relates to systems, software and methods for diagnosing tumor diseases in a patient.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of U.S. Provisional Application No. 62 / 636,135, filed February 27, 2018, the entire contents of which are hereby incorporated by reference. technical field [0003] Embodiments of the present disclosure relate generally to the field of medical diagnostics. In particular, embodiments of the present disclosure relate to compositions, methods and systems for tumor detection and diagnosis. Background technique [0004] The enormous burden of cancer (eg, solid tumors of the lung, breast, prostate, liver, and brain) on human health is well documented in the medical literature. Most subjects were diagnosed with advanced neoplastic disease, which was associated with dismal outcomes. Recently, computed tomography (CT) was found to improve early detection and was used by a US task force to screen high-risk groups. However, this method is limited by a high false positive rate, resulting in e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12Q1/6809G16B40/00
CPCC12Q1/6886C12Q2600/156G16B20/00G16B20/20G16B40/20G16B25/10G16H50/50G06N20/00G06N3/08
Inventor 丹·阿维·兰道阿萨夫·兹维兰史蒂文·柯登-伊尔
Owner CORNELL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap